Vol 33,2024 No.9 | Articles | Chinese Journal of Pharmacoepidemiology

Home Articles Vol 33,2024 No.9

 Contents

Vol 33,2024 No.9

Date of publication: September 15, 2024

 Get cover  Get contents

Signal mining and analysis of adverse events of esketamine based on proportional imbalance method and machine learning algorithms

CHEN Xi LIU Chang LING Yi ZHANG Hewei GUO Xiaojing

2024,33(9):961-970

Esketamine Treatment-resistant depression Adverse drug event Signal detection Disproportional assay Machine learning algorithm FAERS database Pharmacovigilance
Details Download Mobile
Establishment, optimization and practice of an automatic central nervous system adverse reactions monitoring module based on hospital information system data

LI Haiyan GUO Daihong ZHU Man GAO Ao LU Jingchuan FU An LI Chao LI Peng ZHAO Anqi

2024,33(9):971-977

Central nervous system Adverse drug reaction Imipenem/cilastatin Text classification technology Real world study
Details Download Mobile
Efficacy of edaravone dexborneol combined with alteplase in the treatment of acute ischemic stroke: a randomized controlled trial

WU Weijie SUN Zihui XU Liang’e HUANG He HUANG Xuerong

2024,33(9):978-985

Edaravone dexborneol Alteplase Acute ischemic stroke Intravenous thrombolysis Efficacy
Details Download Mobile
Correlation analysis between PPIs and prognosis of AECOPD patients based on MIMIC-Ⅳ database: a retrospective cohort study

WANG Yuan XIN Caixia YANG Haiying CHEN Dan HUANG Na

2024,33(9):986-992

Chronic obstructive pulmonary disease Acute exacerbation Proton pump inhibitor Prognosis MIMIC-Ⅳ Database
Details Download Mobile
Research of medication rules and multi-pathway mechanism of action in the treatment of vitiligo by traditional Chinese medicine compound patent

DONG Xiaoyi JIANG Deyou WANG Zeyun MENG Yuxi MIN Zongfu ZHANG Xuan WANG Shaoying WANG Yuanhong

2024,33(9):993-1005

Vitiligo Traditional Chinese Medicine compound patent Network pharmacology Molecular docking Medication rules Mechanisms of action
Details Download Mobile
Exploring the mechanism of Xiaoshi Lidan pills in the treatment of cholelithiasis based on network pharmacology and UPLC-MS/MS

YUAN Mingyang FU Jinzhou HUANG Zhongqiang YAN Hongmei ZHANG Yisheng LI Juan

2024,33(9):1006-1016

Xiaoshi Lidan pills Cholelithiasis Chemical composition UPLC-MS/MS Network pharmacology
Details Download Mobile
CDK4/6 inhibitors in the first-line treatment of HR+/HER2- advanced stage breast cancer: a rapid health technology assessment

LI Anna XIA Zhengzheng CAI Jiali LIAN Zhuoshi MENG Jun

2024,33(9):1017-1029

CDK4/6 inhibitors Endocrine therapy HR+/HER2- advanced breast cancer Rapid health technology assessment
Details Download Mobile
Four intravenous iron formulations in the treatment of iron deficiency anemia: a rapid health technology assessment

XING Zhicong SUN Fudong XUE Qingxia ZHANG Bei MU Shengjun ZHAO Quan

2024,33(9):1030-1043

Iron sucrose Iron dextran Ferric carboxymaltose Iron isomaltoside Iron deficiency anaemia Rapid health technology assessment
Details Download Mobile
HLA-B*5801 gene polymorphisms detection in prediction of severe drug eruption associated allopurinol: a rapid health technology assessment

CAO Jinjin LING Ya ZHANG Jie ZHANG Jingjing ZHU Jianguo CAO Xiufang

2024,33(9):1044-1053

Allopurinol HLA-B*5801 gene testing Severe drug eruption Rapid health technology assessment
Details Download Mobile
Bibliometric analysis of active surveillance of post-marketing drug safety

WANG Conghui YANG Ziming WANG Zhenxing SHI Wei ALATENG Hua XI Chengwei PI Songning YUAN Xinmin ZHAN Siyan

2024,33(9):1054-1063

Surveillance of post-marketing safety of drugs Active surveillance Pharmacovigilance Bibliometrics Visualization analysis
Details Download Mobile
Research status and hotspot analysis of leech in the field of medicine based on bibliometrics

XIN Quancheng ZHANG Yanzhao HUA Yutong GUO Xiuhuan SU Zhaoyuqing LIU Chuanxin YUAN Ruijuan

2024,33(9):1064-1073

Leech Bibliometrics Visual analysis Hotspot and trend Living application
Details Download Mobile

Clinical pharmacists participated in the drug therapy and pharmaceutical care of a patient with Crohn's disease complicated with erythema multiforme

LI Binbin XU Cuilin HU Naizhong REN Xiaofei WANG Yanyan

2024,33(9):1074-1080

Crohn's disease Erythema multiforme Infliximab Ustekinumab Extraintestinal manifestations Pharmaceutical care
Details Download Mobile